The Daily Papule

Meeting abstracts

SID 2026

Society for Investigative Dermatology · Chicago, 13–16 May 2026

1,233 abstracts, published in JID on 21 July 2026. Their text is on the JID website.

  1. 0003

    A rare case of morphea following zilucoplan treatment for generalized myasthenia gravis

    Kenney S, Hou A, Hwang S

  2. 0004

    B-cell receptor repertoire sequencing reveals frequent rearrangements of IGHD5-5 in systemic sclerosis

    Matsushita T, Fujii K

  3. 0006

    Circulating M1 macrophages associated with cutaneous disease activity in dermatomyositis

    Sagun JP, Leeolou M, … senior author Sarin K

  4. 0007

    Mapping autoantigen reactivity and epitope specificity in autoimmune blistering diseases by molecular indexing of proteins by self-assembly (MIPSA)

    Wang Y, Gainer H, … senior author Amber KT

  5. 0017

    Parkinsonian neuroinflammation increases loss of tolerance and severity in experimental pemphigoid

    Wang Y, Mansini A, … senior author Amber KT

  6. 0020

    Recirculating CD4+ memory T cells in cutaneous lupus are associated with systemic disease and CXCR6–CXCL16 signaling

    Altay UY, Tang Q, … senior author Richmond J

  7. 0025

    Transcriptomic profiling reveals differential organization of immune programs in treatment-refractory bullous pemphigoid

    Roberts BT, Penner SE, … senior author Mangold AR

  8. 0026

    IFNγ-driven CD8+ T cell–keratinocyte crosstalk underlies inflammation and blistering in pemphigus lesions

    Shen Y, Xu C, … senior author Pan M

  9. 0029

    Drug-induced morphea following complement c5 inhibition with zilucoplan: A case report

    Starr E, Behzadpour N, … senior author Emge D

  10. 0033

    Inhibition of complement deposition by methylprednisolone in a human ex vivo model of pemphigoid diseases

    Tigges M, Piccini I, … senior author Bertolini M

  11. 0035

    Non-desmoglein autoantibodies can induce keratinocyte dissociation and potentiate the effects of anti-desmoglein 3 antibodies in pemphigus vulgaris

    Seiffert-Sinha K, Schwartz RR, … senior author Sinha AA

  12. 0037

    T cell receptor repertoire dynamics in pemphigus vulgaris

    Suresha HB, Seiffert-Sinha K, Sinha AA

  13. 0039

    De-repression of LINE-1 associates with activators of type I IFNs in non-lesional lupus keratinocytes

    Gharaee-Kermani M, Henning S, … senior author Kahlenberg M

  14. 0040

    Mitochondrial stress and mavs mediated interferon signaling in dermatomyositis skin

    Schedler N, Kolmetzky D, … senior author Edminister J

  15. 0042

    Analysis of the serum proteome in bullous pemphigoid reveals inflammatory and remodeling co-expression networks

    Mansini A, Wang Y, … senior author Amber KT

  16. 0043

    Inhibition of VEGF-A decreases disease severity in experimental pemphigoid

    Wang Y, Li J, … senior author Amber KT

  17. 0048

    Multiplexed serum proteomics explores molecular-level lipid pathway dysregulation in cutaneous lupus

    Homer RO, Jones B, … senior author Network A

  18. 0050

    Subtype-specific HLA allele heterogeneity in bullous pemphigoid and mucous membrane pemphigoid

    Zel R, Seiffert-Sinha K, Sinha AA

  19. 0053

    Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease

    Penner SE, Roberts BT, … senior author Mangold AR

  20. 0058

    Decreased rate of cardiovascular events with GLP-1 receptor agonist use in dermatomyositis and lupus patients

    Wei E, Saksena S, … senior author Werth VP

  21. 0061

    Prevalence of IgE bullous pemphigoid autoantibodies and association with disease status

    Noot C, Seely M, … senior author Hopkins Z

  22. 0072

    Deciphering microenvironment dysregulation in pemphigus skin lesions through spatial transcriptomics

    Ke H, Wang H, … senior author Pan M

  23. 0073

    Single-cell analysis reveals divergent dendritic cell-fibroblast signaling in lesional versus non-lesional cutaneous lupus

    Herrera DB, Srikumar A, … senior author Kang J

  24. 0076

    Single-cell and spatial profiling reveal distinct fibrotic programs in stiff skin syndrome and systemic sclerosis

    Dey P, Bogle R, … senior author Gudjonsson JE

  25. 0129

    Heterogenous plasmacytoid dendritic cell states orchestrate interferon-rich microenvironment in cutaneous lupus

    Jun S, Srikumar A, … senior author Network A

  26. 0130

    COL11A1 fibroblasts and epithelial-stromal crosstalk underlie early fibrotic priming in discoid lupus

    Srikumar A, Jun S, … senior author Network A

  27. 0165

    Nuclear galectin 3-EGFR complex regulates skin fibrosis in systemic sclerosis

    Odell AV, Jiang K, … senior author Odell ID

  28. 0170

    CaMKII integrates calcium signaling and oxidative stress to promote fibrosis in scleroderma fibroblasts

    Kataria S, Ikari Y, … senior author Tsou P

  29. 0222

    Recurrent extramedullary blastic plasmacytoid dendritic cell neoplasm (BPCDN) initially presenting with clinical and histopathologic features of lupus erythematosus

    Salem IM, Fontaine D, … senior author Yan SM

  30. 0283

    Associations between bullous pemphigoid and autoimmune diseases: Evidence from electronic health records and mendelian randomization

    Nguyen H, Huang Y

  31. 0287

    Characteristics of myositis in eosinophilic fasciitis: A retrospective cohort study

    Zappi I, Martin MR, … senior author Mazori D

  32. 0305

    Diagnostic testing and disease phenotypes in ocular pemphigoid: A retrospective review

    Seely MM, Hull C, … senior author Hopkins Z

  33. 0323

    Rituximab monotherapy versus combination immunosuppression in pemphigus vulgaris: An infection risk analysis

    Saksena S, Yang X, … senior author Werth VP

  34. 0326

    Higher neutrophil-to-lymphocyte ratio associates with acral-predominant cutaneous involvement and greater cutaneous disease activity in adult dermatomyositis

    Mahgerefteh N, Srikumar A, Kang J

  35. 0333

    Site-specific remission patterns in multisite mucous membrane pemphigoid: Experience at an academic tertiary center

    McAleer L, La T, … senior author Dominguez A

  36. 0368

    Refractory lupus panniculitis with intractable pain: A multidisciplinary inpatient management challenge

    Kim I, Oquet RH

  37. 0384

    Drug-induced subacute cutaneous lupus erythematosus: Real-world outcomes

    Orofino J, Whittelsey M, … senior author LaChance A

  38. 0391

    Methotrexate monotherapy has comparable long-term outcomes to methotrexate plus corticosteroids in the treatment of morphea

    Shah VK, Lateef A, … senior author Jacobe H

  39. 0399

    Integrating patient-reported and population-level data to characterize mental health burden in pemphigus

    Baroukhian J, Zel R, … senior author Sinha AA

  40. 0410

    Discontinuation and results dissemination in cutaneous lupus erythematosus clinical trials: Insights from a global registry analysis

    Brudzinski A, Hrabak C, … senior author Ashurst J

  41. 0428

    No increased risk of aplastic anemia associated with quinacrine treatment in lupus patients

    Wei E, Jun S, … senior author Werth VP

  42. 0434

    Advancing transparency and evidence synthesis in rare autoimmune blistering diseases: Insights from pemphigus vulgaris and mucous membrane pemphigoid clinical trials

    Brudzinski A, Hrabak C, … senior author Ashurst J

  43. 0435

    Characterization and management of cutaneous ulcers in anti-MDA5-positive dermatomyositis: A systematic review

    Ocejo S, Ostroff E, … senior author Vakharia P

  44. 0442

    Development of consensus-based outcome measures for morphea clinical trials: A delphi study

    Le V, Hirsh R, … senior author Wetter DA

  45. 0461

    Anifrolumab is associated with lower infection risk and improved skin activity in refractory cutaneous lupus compared to conventional immunosuppressants

    Srikumar A, Urbanski N, Kang J

  46. 0479

    Hydroxychloroquine use and atherosclerotic cardiovascular risk in isolated discoid lupus erythematosus

    Srikumar A, Yuvchenko O, Kang J

  47. 0488

    Rapid molecular and clinical improvement in cutaneous dermatomyositis with brepocitinib: Results from a phase 2 trial

    Mangold AR, Jiang R, … senior author Gudjonsson JE

  48. 0544

    Cosmetic procedures in craniofacial morphea: A multicenter study of disease recurrence and outcome measures

    Ahuja R, Rose EK, … senior author Jacobe H

  49. 0546

    Cardiovascular and thromboembolic risk of janus kinase inhibitor use in dermatomyositis patients: A retrospective cohort analysis

    Park JH, Ramos-Briceño DA, … senior author Femia AN

  50. 0660

    Tissue and single-cell profiling identify skin-intrinsic neutrophil extracellular trap-type I interferon programs in hydroxychloroquine-resistant discoid lupus

    Srikumar A, Patel S, … senior author Kang J